Format

Send to

Choose Destination
See comment in PubMed Commons below
Breast Cancer Res Treat. 2008 Apr;108(3):351-61. Epub 2007 Jun 26.

Estrogen receptors outside the nucleus in breast cancer.

Author information

1
University of California, Irvine/VA Long Beach Healthcare System, VALBHS, Long Beach, CA, USA. ellis.levin@va.gov

Abstract

The estrogen receptor (ER) is the single most powerful predictor of breast cancer prognosis as well as an important contributor to the biology of carcinogenesis. In addition, endocrine therapy targeting ER directly (SERMS) or indirectly (aromatase inhibitors) forms the mainstay of adjuant therapy. Traditionally, human tumors are scored for the amount and presence of ER. However, this has centered on the population of ER found in the transformed epithelial cell nucleus. Over the last 40 years, it has been appreciated that additional cellular ER pools exist, in cytoplasm and at the plasma membrane. In this review, we discuss the important functions of extra-nuclear ER in breast cancer, including integration of function with nuclear ER.

PMID:
17592774
DOI:
10.1007/s10549-007-9618-4
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center